Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cosmos Health Inc COSM

Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals... see more

Recent & Breaking News (NDAQ:COSM)

Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

GlobeNewswire September 21, 2021

Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company's Senior Lender, Further Enhancing the Balance Sheet

GlobeNewswire August 18, 2021

Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter of 2021

GlobeNewswire August 17, 2021

Cosmos Holdings to Open Flagship Store on Alibaba's Tmall Global, World's Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users

GlobeNewswire August 10, 2021

Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share

GlobeNewswire July 26, 2021

Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share

GlobeNewswire July 16, 2021

Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria

GlobeNewswire July 8, 2021

Cosmos Holdings Appoints Finance Veteran Alexi Papaconstantinou to its Advisory Board

GlobeNewswire July 1, 2021

Cosmos Holdings CEO Greg Siokas Converts $3.0 Million of Debt into Common Stock at $6.00 Per Share

GlobeNewswire June 28, 2021

Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business

GlobeNewswire May 18, 2021

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon UK

GlobeNewswire April 27, 2021

Cosmos Holdings Reports Revenue Growth of 40% to a Record $55.4 Million and Achieves Profitability for 2020

GlobeNewswire April 16, 2021

Cosmos Holdings Launches Proprietary King Eros and Queen Venus Supplements for Enhanced Libido

GlobeNewswire April 14, 2021

Cosmos Holdings Launches Mosept-Oral Antiseptic Spray Designed to be Effective Against Bacteria and Certain Viral Pathogens

GlobeNewswire April 8, 2021

Cosmos Holdings Launches Osteodome in EU

GlobeNewswire February 11, 2021

Cosmos Holdings Launches New Proprietary Enhanced Dietary Supplement

GlobeNewswire January 11, 2021

Cosmos Holdings Announces December 4th Virtual Bell Ringing to Open Trading on the OTCQX Best Market

GlobeNewswire December 4, 2020

Cosmos Holdings Begins Trading on the OTCQX® Best Market

GlobeNewswire November 25, 2020

OTC Markets Group Welcomes Cosmos Holdings Inc. to OTCQX

PR Newswire November 25, 2020

Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results

GlobeNewswire November 17, 2020